Clinical Trials Browser

Phase 2 × Enrolling by invitation × Multiple Myeloma × Clear all

NCT03628612 2025-08-07

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Phase 2 Enrolling by invitation

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell